Jobelle Baldonado, MD

Cancer Focus:
Esophageal Cancer, Lung Cancer, Mesothelioma, Pancoast Tumor, Thymoma

Dr. Baldonado received her MD degree from the University of the Philippines College of Medicine. She remained at the University of the Philippines to complete an integrated residency in Thoracic and Cardiovascular Surgery. She then completed a Minimally Invasive Thoracic Surgical Oncology Fellowship at Moffitt Cancer Center, followed by a Cardiovascular Surgery Fellowship at the Mayo Clinic in Rochester, Minnesota.

 

Dr. Baldonado’s clinical interests are in minimally invasive lung cancer and esophageal cancer surgery, including lobectomy, segmentectomy, esophagectomy, and the management of chest wall tumors. Her research interests focus on ground glass opacities as initial presentation of lung cancers as well as surgical outcomes.

Education & Training

Fellowship:

• Moffitt Cancer Center - Thoracic Surgery
• Mayo Clinic - Cardiovascular Surgery

Medical School:

• University of the Philippines - MD

Clinical Trial 23397
Surgical Drain Fluid for Detection of Molecular Residual Disease (MRD) in Patients with Non-Small Cell Lung Cancer
Condition: Thoracic
Status: Open

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.

• Karapetyan L, Kuriakose J, DiMaggio E, Ward K, Chau J, Otteni C, Kalos D, Ali J, Hall MS, Beatty M, Klinkova OV, Alomar ME, Gaskill EE, Gonzalez RM, Bailey H, Yu M, Tran N, Rodriguez-Alfonso L, Vieira E, Adams K, Jain M, Locke FL, Baldonado J, Perez MC, Mullinax J, Zager JS, Gonzalez R, Sondak VK, Markowitz J, Brohl AS, Eroglu Z, Tarhini AA, Khushalani NI, Mulé JJ, Sarnaik AA, Pilon-Thomas S. Safety and Efficacy of Tumor-Infiltrating Lymphocyte Therapy with Reduced-Dose Lymphodepleting Conditioning in High-Risk Metastatic Melanoma Patients. Transplant Cell Ther. 2026 Mar.32(3):290.e1-290.e14. Pubmedid: 41421538.
• Sinnamon AJ, Saeed SH, Pereira AAL, Mehta R, Drake JA, Mok SRS, Lauwers GY, Frakes JM, Hoffe SE, Baldonado JJ, Fontaine JP, Pimiento JM. Long-term Oncologic Outcomes Following Pathologic Complete Response for Esophageal Cancer. Ann Surg Oncol. 2026 Mar.33(3):2056-2064. Pubmedid: 41193821.
• Sinnamon AJ, Saeed S, Lima Pereira AA, Mehta R, Drake JA, Mok SRS, Lauwers GY, Frakes JM, Hoffe SE, Baldonado JJ, Fontaine JP, Pimiento JM. ASO Visual Abstract: Long-Term Oncologic Outcomes Following Pathologic Complete Response for Esophageal Cancer. Ann Surg Oncol. 2026 Mar.33(3):2153-2154. Pubmedid: 41361153.
• Robinson LA, Robinson NA, Kim Y, Bailey A, El-Haddad G, Fontaine JP, Toloza EM, Frealdenhoven ST, Baldonado JJAR, Bryant S, Schwer T, Kis B. Practical therapeutic options for postoperative chylothorax. J Cardiothorac Surg. 2026 Apr.21(1). Pubmedid: 42010603. Pmcid: PMC13231676.
• Singh P, Choo S, Adams J, Adams M, Lima Pereira AA, Baldonado JJA, Fontaine JP, Sandoval ML, Frakes JM, Pimiento JM, Hoffe SE, Sinnamon AJ. Is Site of Radiation Therapy Associated With Pathologic Complete Response in Patients With Locally Advanced Esophageal Cancer?. Cancer Control. 2025 Sep.32. Pubmedid: 40992780. Pmcid: PMC12461076.
• Shannon AB, Mehta R, Mok SR, Lauwers GY, Baldonado JJAR, Fontaine J, Pimiento JM, Sinnamon AJ. ASO Visual Abstract: Clinical and Pathologic Response to Neoadjuvant Immunotherapy in DNA Mismatch Repair Protein-Deficient Gastroesophageal Cancers. Ann Surg Oncol. 2025 Jan.32(1):581-582. Pubmedid: 39412693.
• Saeed SH, Sinnamon AJ, Fontaine JP, Mehta RJ, Baldonado JJR, Pena LR, Pereira AAL, Hoffe SE, Frakes JM, Pimiento JM. Survival after esophagectomy for metastatic esophageal cancer: should the role of surgery be reconsidered?. J Gastrointest Surg. 2025 Aug.29(8):102118. Pubmedid: 40513811.
• Saeed SH, Sinnamon AJ, Fontaine JP, Mehta RJ, Pena LR, Mok SRS, Baldonado JJR, Pimiento JM. Intra-operative pyloric BOTOX injection versus pyloric surgery for prevention of delayed gastric emptying after esophagectomy. Surg Endosc. 2024 Oct.38(10):6046-6052. Pubmedid: 39134721.
• Shannon AB, Mehta R, Mok SR, Lauwers GY, Baldonado JJAR, Fontaine J, Pimiento JM, Sinnamon AJ. Clinical and Pathologic Response to Neoadjuvant Immunotherapy in DNA Mismatch Repair Protein-Deficient Gastroesophageal Cancers. Ann Surg Oncol. 2024 Dec.31(13):8616-8626. Pubmedid: 39154152.
• Drake JA, Sinnamon AJ, Saeed S, Mehta R, Palm RF, Baldonado JJ, Fontaine JP, Pimiento JM. Totally minimally invasive laparoscopic robot-assisted Ivor Lewis esophagectomy: improved technique and outcomes over 200 cases. J Gastrointest Oncol. 2024 Apr.15(2):544-554. Pubmedid: 38756649. Pmcid: PMC11094488.
• Sinnamon AJ, Mehta R, Saeed S, Lauwers GY, Palm RF, Frakes JM, Hoffe SE, Baldonado JJ, Fontaine JP, Pimiento JM. Induction Fluorouracil-Based Chemotherapy and PET-Adapted Consolidation Chemoradiation with Esophagectomy for High-Risk Gastroesophageal Adenocarcinoma. Cancers (Basel). 2023 Sep.15(17). Pubmedid: 37686650. Pmcid: PMC10486661.
• Baldonado JJAR, Naffouje SA, Parvathaneni S, Roy E, Toloza EM, Fontaine JP. Outcomes of robotic lobectomy for non-small cell lung cancer in a National Cancer Institute-Comprehensive Cancer Center vs. National Cancer Database. J Thorac Dis. 2023 Oct.15(10):5349-5361. Pubmedid: 37969299. Pmcid: PMC10636448.
• Aboukheir Aboukheir A, Villanueva EQ, Garrett JR, Moodie CC, Tew JR, Toloza EM, Fontaine JP, Baldonado JJAR. Association between the Preoperative Standard Uptake Value (SUV) and Survival Outcomes after Robotic-Assisted Segmentectomy for Resectable Non-Small Cell Lung Cancer (NSCLC). Cancers (Basel). 2023 Nov.15(22). Pubmedid: 38001639. Pmcid: PMC10670906.
• Doyle WN, Nguyen D, West WJ, Fiedler CR, Labib KM, Ladehoff L, Dumitriu Carcoana AO, Marek JC, Malavet JA, Moodie CC, Garrett JR, Tew JR, Baldonado JJAR, Fontaine JP, Toloza EM. Changes in Perioperative Outcomes after Robotic-Assisted Pulmonary Lobectomy during the COVID-19 Era. Surg Pract Sci. 2023 Jun.13:100172. Pubmedid: 37139165. Pmcid: PMC10125211.
• Chase CB, Mhaskar R, Fiedler C, West WJ, Varadhan A, Cobb J, Cool S, Fishberger G, Dolorit M, Weeden EE, Strang HE, Nguyen D, Garrett JR, Moodie CC, Fontaine JP, Tew JR, Baldonado JJAR, Toloza EM. Effects of preoperative pulmonary function on perioperative outcomes after robotic-assisted pulmonary lobectomy. Am J Surg. 2023 Jul.226(1):128-132. Pubmedid: 37121787.
• Dumitriu Carcoana AO, Labib KM, Fiedler CR, Marek JC, Ladehoff LC, West WJ, Malavet JA, Doyle WN, Moodie CC, Garrett JR, Tew JR, Baldonado JJAR, Fontaine JP, Toloza E. A High Preoperative Blood Urea Nitrogen to Serum Albumin Ratio Does Not Predict Worse Outcomes Following the Robotic-Assisted Pulmonary Lobectomy for Lung Cancer. Cureus. 2023 Dec.15(12):e50468. Pubmedid: 38222193. Pmcid: PMC10786433.
• Dutta M, Toloza EM, Nguyen D, Mhaskar R, Fishberger G, Fontaine JP, Baldonado JJAR. Effect of octogenarian status on outcomes after robotic-assisted pulmonary lobectomy for primary lung cancer. Geriatr Oncol. 2023 Apr.14(3):101470. Pubmedid: 36989938.
• Baldonado JJAR, Amaral M, Garrett J, Moodie C, Robinson L, Keenan R, Toloza EM, Fontaine JP. Credentialing for robotic lobectomy: what is the learning curve? A retrospective analysis of 272 consecutive cases by a single surgeon. J Robot Surg. 2018 Dec.13(5):663-669. Pubmedid: 30560496.
• Abrahan Iv LL, Obillos SMO, Aherrera JAM, Magno JDA, Uy-Agbayani CCC, Gopez UKG, Baldonado JJAR. A Rare Case of Pneumopericardium in the Setting of Tuberculous Constrictive Pericarditis. Case Rep Cardiol. 2017 Jun.2017:4257452. Pubmedid: 28634555. Pmcid: PMC5467283.
• De Roxas RC, Bagnas MA, Baldonado JJ, Rivera JP, Roxas AA. Clinical Profile and Outcome of Postthymectomy versus Non-Thymectomy Myasthenia Gravis Patients in the Philippine General Hospital: A 6-Year Retrospective Study. Front Neurol. 2016 Jun.7:96. Pubmedid: 27445963. Pmcid: PMC4914503.

Voted top doctor in Thoracic Disease in Tampa Magazine's Top Doctors 2025.

Voted top doctor in Thoracic Disease in Tampa Magazine's Top Doctors 2024.